Skip to main content
. 2012 Mar 22;302(11):G1310–G1321. doi: 10.1152/ajpgi.00365.2011

Table 2.

Body/liver/fat weight and lipid level at 22 wk after the CSAA and CDAA diet feeding

CSAA
CDAA
WT mice (n = 5) CCR2−/− mice (n = 5) WT mice (n = 10) CCR2−/− mice (n = 10)
Body weight, g, start, wk = 0 22.0 ± 1.0 22.8 ± 0.9 22.5 ± 1.1 22.3 ± 1.1
Body weight, g, end, wk = 22 39.4 ± 1.1 32.4 ± 2.3* 39.6 ± 2.0 30.6 ± 2.7*
Liver weight, g 2.07 ± 0.03 1.25 ± 0.10* 2.55 ± 0.23* 1.73 ± 0.32
Liver weight, % 5.26 ± 0.13 3.88 ± 0.15* 6.41 ± 0.29* 5.65 ± 0.70
Epididymal fat, g 2.33 ± 0.15 1.08 ± 0.40* 2.35 ± 0.30 1.11 ± 0.39*
Epididymal fat, % 5.91 ± 0.36 3.30 ± 1.08* 5.94 ± 0.73 3.57 ± 1.01*
Plasma
    Triglyceride, mg/dl 32.6 ± 7.8 30.0 ± 6.4 47.6 ± 9.1* 37.8 ± 9.5
    Total cholesterol, mg/dl 154.0 ± 16.7 135.8 ± 16.6 86.6 ± 21.6* 73.4 ± 7.9*
    Free fatty acid, mM 0.47 ± 0.12 0.32 ± 0.71 0.49 ± 0.15 0.34 ± 0.93
HOMA-IR 2.74 ± 0.50 1.28 ± 0.27* 2.86 ± 0.58 1.25 ± 0.17*

Values are means ± SD.

*

Significantly different from wild-type (WT)-choline-supplemented amino acid-defined (CSAA), P < 0.05.

Significantly different from WT-choline-deficient amino acid-defined (CDAA), P < 0.05.

Significantly different from CCR2−/−-CSAA, P < 0.05. HOMA-IR, homeostasis model assessment of insulin resistance.